Healthcare Scan

Scan

Healthcare Scan

Scan symbols 19
ABTAMGNBIIBCVSDXCMGILDGRDNISRGJNJLLYMDTMRKMRNAPFESYKTMOUNHVEEVVRTX
Watchlists 1
@healthcare-scan
raw scan snapshot — prices as of scan date, not live 34 rows · screens, not recommendations ported fromresearch/classic/scans/_archive/2026-04-28-healthcare-scan.mdscan slughealthcare-scansource typescan-archive

Healthcare under broad pressure — VEEV (-49% from high), DXCM (-34%), ABT (-33%), MDT (-23%) all in deep deathcross territory. UNH bouncing off catastrophic -47% drawdown (+9.6% 30D, RSI 67.6). CVS and TMO are the rare strong-up names.

Quick Snapshot

Signal Reading
Overall 🔴 Bearish — most large-caps in strong-down trend, multiple deathcrosses, healthcare ETFs underperforming
Leaders CVS (+16.5% 30D, RSI 65, strong-up), UNH (+9.6% 30D recovery), TMO (+9.4% 30D), GRDN (+22.5% 3M strong-up)
Laggards VEEV (-13% 7D, -49% from high, RSI 33), DXCM (RSI 34, -34% from high), MRNA (-13% 7D), ABT (RSI 36, -33% from high)
Key insight Medical devices in trouble (MDT, DXCM, ISRG, SYK all strong-down with deathcrosses); life sciences tools too (TMO and IQV broken); only insurance (CVS, UNH) and obesity-related pharma (LLY despite breakdown) keeping pulse

Price Table

Stock Price RSI vs SMA20 7D% 30D% 3M% 52wkHi Trend Signal
SYK $347.24 55.8 +3.6% +1.60% -0.40% -3.12% -14.23% strong-down 🔍 Watch
ISRG $466.64 48.5 +0.7% +1.46% +3.06% -8.06% -22.73% strong-down 🔍 Watch
MDT $81.90 32.6 ↓ -4.4% -2.36% -4.48% -18.25% -22.98% strong-down 🔍 Watch
DXCM $59.32 33.9 ↓ -5.7% -4.06% -4.17% -19.84% -34.07% strong-down 🔍 Watch
ABT $93.86 36.5 ↓ -4.2% -2.08% -7.29% -10.97% -32.50% strong-down 🔍 Watch
PFE $26.48 41.5 -3.1% -2.26% -4.65% +1.46% -7.90% weak-down 🔍 Watch
MRK $110.03 35.7 ↓ -6.4% -2.96% -6.83% +2.32% -12.07% weak-down 🔍 Watch
LLY $874.00 37.6 ↓ -5.0% -3.22% -1.42% -14.52% -22.92% down 🔍 Watch
GILD $129.26 32.4 ↓ -5.6% -4.24% -5.19% -6.85% -17.82% weak-down 📈 Accumulate
AMGN $339.57 39.3 -2.4% -0.86% -2.70% -0.30% -13.22% weak-down 🔍 Watch
BIIB $183.38 51.3 +1.7% -3.28% -2.23% +4.09% -9.40% weak-down 🔒 Hold
JNJ $227.79 38.5 -3.3% -0.47% -6.06% +0.75% -9.50% weak-down 🔍 Watch
UNH $313.00 67.6 ↑ +10.7% +7.65% +9.64% -5.83% -47.45% up 🔍 Research
CVS $80.98 65.0 +6.1% +1.10% +16.47% +9.74% -4.90% strong-up 🔒 Hold
VEEV $158.45 32.9 ↓ -9.4% -13.25% -14.48% -27.60% -48.97% strong-down 🔍 Research
TMO $514.23 58.9 +5.8% +1.59% +9.41% -17.22% -20.15% weak-up 🔍 Watch
VRTX $440.05 44.1 -1.6% -0.56% -5.59% -2.11% -13.85% weak-down 🔍 Watch
MRNA $47.14 37.3 ↓ -8.8% -12.65% -2.26% +0.60% -20.84% weak-down 🔍 Watch
GRDN $37.59 53.7 -1.0% +2.46% +0.91% +22.52% -9.12% strong-up 🔒 Hold

Tier Analysis

Tier 1 — Strong Up (Working)

  • CVS ($80.98, RSI 65, +16.5% 30D) — pharmacy/insurer rally, strong-up, golden cross, near 52wk high.
  • GRDN ($37.59, +22.5% 3M) — strong-up, +27.8% above SMA200, golden cross.
  • TMO ($514, +9.4% 30D) — life sciences tools rebounding, weak-up but recovering.

Tier 2 — Bouncing Hard

  • UNH ($313, RSI 67.6, +9.6% 30D) — recovering from -47% drawdown. Up trend now active but deathcross still on books. Watch for confirmation of reversal.

Tier 3 — Quality on Sale

  • GILD ($129, RSI 32.4) — approaching oversold, +145% 5y, alpha intact. Best entry in pharma.
  • AMGN ($340, RSI 39) — quality holding above SMA200.
  • JNJ ($228, RSI 38) — defensive name pulled back -6% 30D.
  • MRK ($110, RSI 35.7) — large pharma in pullback, +37% 1y.
  • PFE ($26.48) — basing, +17% 1y, holding above SMA200.

Tier 4 — Strong-Down Breakdowns (Caution)

  • VEEV ($158, RSI 32.9, deathcross) — life sciences SaaS broken, -49% from high.
  • DXCM ($59, deathcross) — CGM thesis fading, -34% from high, -20% 3M.
  • ABT ($94, RSI 36.5, deathcross) — medtech leader broken, -33% from high.
  • MDT ($82, RSI 32.6, deathcross) — medical devices weakening.
  • ISRG ($467, deathcross) — surgical robotics in pullback, -23% from high.
  • SYK ($347, deathcross) — orthopedics weakening.

Tier 5 — Mega-Cap Pharma in Pullback

  • LLY ($874, RSI 37.6) — GLP-1 king losing altitude, -14.5% 3M, -23% from high.
  • MRNA ($47, RSI 37.3) — vaccine maker, -13% 7D.
  • VRTX ($440, RSI 44) — CF franchise, -14% from high.
  • BIIB ($183, RSI 51) — Alzheimer franchise, holding flat.

Entry Zones

Stock Price Zone RSI 30D% Setup
GILD $129.26 <$130 32.4 ↓ -5.19% Approaching oversold, quality dividend pharma, +145% 5y
MDT $81.90 <$85 32.6 ↓ -4.48% Deep oversold but deathcross — wait for stabilization
MRK $110.03 $108-115 35.7 ↓ -6.83% Pulled back from rally, holding above SMA200 (+11.9%)
ABT $93.86 $90-95 36.5 ↓ -7.29% Quality medtech in deep pullback, -33% from high
VEEV $158.45 <$160 32.9 ↓ -14.48% Falling knife — wait for capitulation; -49% from high already
DXCM $59.32 <$60 33.9 ↓ -4.17% Multi-year breakdown, broken thesis — not in entry zone
LLY $874 <$850 37.6 -1.42% Obesity king cooling, watch for $850 floor

Action Matrix

Action Stocks Why
🔒 HOLD CVS, GRDN, BIIB Strong-up trends, near highs
📈 ACCUMULATE GILD RSI 32.4, dividend pharma at discount
🔍 WATCH AMGN, JNJ, MRK, PFE, LLY, AMGN, VRTX, TMO, ISRG, SYK, MDT, ABT, DXCM, MRNA Pulling back, mostly quality but trend turning
🔍 RESEARCH UNH, VEEV UNH: real reversal off catastrophic drawdown? VEEV: deep value or value trap?

What Changed (vs April 10 scan)

  • VEEV is broken — was RSI 22 capitulation candidate, now RSI 32.9 with weak bounce. -27.6% 3M. The thesis (life sciences SaaS) is being repriced.
  • MDT in fresh breakdown — moved into deathcross with -18.25% 3M decline.
  • DXCM continues failing — was already weak, now -34% from high.
  • ABT new strong-down — added to the medtech-broken pile, -32.5% from high.
  • CVS broke out — was sleepy, now +16.5% 30D and strong-up. Insurer/pharmacy rotation into defensive.
  • UNH started recovering — was in freefall, +9.6% 30D bounce off -47% drawdown.
  • LLY trend changed — was leadership name, now down trend with -22.9% from high.
  • GILD slid into oversold — RSI 32.4 (was 50). Best entry zone of the cohort.
  • TMO improving — moved from weak-down to weak-up, +9.4% 30D.
  • MRNA cooling — was strong-up at +54% 3M in April, now weak-down with -13% 7D.
10 events
DateTypeEvent
Apr 26 ScanHealthcare Scan Apr 13 Scan2 — HEALTHCARE SCAN Apr 10 ScanHealthcare Scan Apr 3 ScanHealthcare Scan Mar 31 ScanHealthcare Scan May 29 ScanHealthcare Scan Jun 16 ScanHealthcare Scan Jun 20 ScanHealthcare Scan Apr 28 ScanBiotech Scan Jun 25 ScanHealthcare Scan

No direct external sources are attached to this read.